Julia Lainster

Julia Lainster

HealthTech Solutions Expert
Julia Lainster is an expert in Healthtech with a focus on electronic health records, interoperability standards, and cybersecurity. Her content is geared toward industry leaders and organizations seeking to leverage technology to improve efficiency, accuracy, and security in healthcare delivery. Julia aims to drive digital transformation and innovation in Healthtech.
FDA Approves Oral Wegovy Pill for Weight Loss
Management & Regulatory FDA Approves Oral Wegovy Pill for Weight Loss

With the recent FDA approval of Novo Nordisk's oral version of Wegovy, the landscape of weight management treatment is poised for a monumental shift. We sat down with biopharma expert Ivan Kairatov, whose extensive background in research and development offers a unique lens on this

Study Tackles Bowel Cancer's Drug Resistance
Research & Development Study Tackles Bowel Cancer's Drug Resistance

A concerning and rapid increase in bowel cancer diagnoses among younger adults has added a new layer of urgency to one of oncology's most persistent challenges: the ability of tumors to develop resistance to standard treatments. This growing crisis highlights a critical gap in medical science, as

AI-Driven Gene Network Analysis – Review
Tech & Innovation AI-Driven Gene Network Analysis – Review

For decades, the blueprint of disease has been read one letter at a time, searching for single genetic misspellings, yet this approach has consistently fallen short of explaining the full narrative of complex illnesses like cancer. The emergence of AI-driven gene network analysis represents a

Can Light Revolutionize Blood Diagnostics?
Tech & Innovation Can Light Revolutionize Blood Diagnostics?

Today we're joined by Ivan Kairatov, a biopharma expert at the forefront of medical diagnostics. For decades, the cornerstone of blood analysis has been the microscope, a tool reliant on human interpretation. But what if we could teach a machine to see the invisible signs of disease in a single

Study Finds Novel Enzyme Target for Alzheimer's Treatment
Research & Development Study Finds Novel Enzyme Target for Alzheimer's Treatment

In the relentless search for effective Alzheimer's treatments, where many promising paths have led to dead ends, researchers are now turning their attention to a rather unlikely source: an enzyme responsible for producing the gas that gives rotten eggs their infamous smell. This enzyme,

Insilico Partners With TaiGen on AI-Discovered Anemia Drug
Tech & Innovation Insilico Partners With TaiGen on AI-Discovered Anemia Drug

For the more than one in seven individuals battling chronic kidney disease who also suffer from anemia, treatment has often meant managing debilitating symptoms rather than addressing the underlying cause. This reality is poised for a significant change, as a landmark collaboration between

Epigenetic Aging Clocks – Review
Tech & Innovation Epigenetic Aging Clocks – Review

The quest to measure the true pace of human aging has moved from the realm of speculation into the molecular precision of the laboratory, powered by a technology that reads the subtle chemical tags accumulating on our DNA over a lifetime. The technology of epigenetic aging clocks represents a

Breast Cancer Drug Combo Overcomes AML Resistance
Research & Development Breast Cancer Drug Combo Overcomes AML Resistance

For patients diagnosed with acute myeloid leukemia, a notoriously aggressive blood cancer, the current standard of care initially offers a powerful ray of hope, but this victory is often fleeting as the treatment almost always fails when the cancer learns to outsmart it. This life-saving therapy

AI Reveals New Neuron Types Driving Covert Attention
Tech & Innovation AI Reveals New Neuron Types Driving Covert Attention

The human mind performs a constant, silent miracle of selection, effortlessly plucking a single voice from a cacophony of conversation or spotting a friend’s face in a bustling crowd, all without so much as a flicker of the eyes. This profound ability, known as covert attention, allows us to

How Common Is Hidden Alzheimer's Pathology?
Research & Development How Common Is Hidden Alzheimer's Pathology?

For decades, the diagnosis of Alzheimer’s disease has been a process of exclusion, often coming too late, after irreversible damage has been done. But the ground is shifting beneath our feet. With the advent of simple blood tests, we are entering a new era of proactive neurological health. To help

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later